Employee Comment: BUS-50 Controlled Substances Use in Research and Teaching

The University of California Office of the President invites comments on a proposed Presidential Policy BFB-BUS-50: Controlled Substances Use In Research and Teaching. The policy is proposed to be revised and includes the following key issues: 

• Clarify in detail the scope of duties of the Campus Controlled Substances Programs and the Controlled Substances Program Officers;
• Define the Campus Designation form of Drug Enforcement Agency (DEA) Registration and address requirements applicable to DEA Registrations other than Campus Designation, such as individual schedule I DEA Registrations;
• Provide more specific procedures regarding Powers of Attorney;
• Provide additional guidance as to import, export, interstate and intrastate use, transfer and transport of Controlled Substances, as well as Controlled Substances Analogues and DEA-exempt chemical preparations; and
• Establish responsible units and individuals for patient care and clinical Controlled Substances Program.

The proposed revisions to the policy may be viewed at https://ucanr.edu/sites/PCPA/Revisions/.

If you have any questions or if you wish to comment on this policy revision, please contact Robin Sanchez at rgsanchez@ucanr.edu, no later than April 5, 2024. Please indicate “BUS-50 Revision” in the subject line.

Read more